LifeStance Health (LFST) Acquisitions (2020 - 2026)

LifeStance Health (LFST) has reported Acquisitions for 5 consecutive years, with $3.1 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Acquisitions changed N/A year-over-year to $3.1 million; the TTM figure through Mar 2026 stood at $3.1 million (changed N/A YoY), while the FY2023 annual figure was $19.8 million, down 67.08% from the prior year.
• Acquisitions slipped to $3.1 million in Q1 2026 per LFST's latest filing, from $19.8 million in the prior quarter.
• Across five years, Acquisitions topped out at $22.9 million in Q1 2022 and bottomed at $3.1 million in Q1 2026.
• Historically, Acquisitions has averaged $13.9 million across 3 years, with a median of $16.0 million in 2022.
• On a YoY basis, Acquisitions climbed as much as 2943.1% in 2022 and fell as far as 51.3% in 2022.
• LifeStance Health's Acquisitions stood at $19.9 million in 2022, then slipped by 0.46% to $19.8 million in 2023, then sank by 84.14% to $3.1 million in 2026.
• Business Quant data shows LFST's Acquisitions at $3.1 million in Q1 2026, $19.8 million in Q1 2023, and $19.9 million in Q4 2022.